25 completed, 6 unknown, 5 terminated, 1 withdrawn. 16 Phase 1, 7 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Completed 12, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 4, Terminated 3 |
| Not applicable | 2 | Completed 1, Unknown 1 |
Follow Chromatography, High Pressure Liquid: new trials by email Literature Review of Chromatography, High Pressure Liquid trials Research Report on Chromatography, High Pressure Liquid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Association of Bisphenol A,Paraben Exposure and Type 2 Diabetes HPLC - Type2 Diabetes, Bisphenol A | Not applicable | Unknown | Cairo University | 100 | 2022-02-20 | 2022-07-27 |
| Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline citalopram hydrobromide, escitalopram oxalate, gabapentin - Breast Cancer, Depression | Completed | Mayo Clinic | 88 | 2011-03-16 | 2025-02-14 | |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors pralatrexate, fluorouracil, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | University of Nebraska | 29 | 2010-09-14 | 2023-12-26 |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers high performance liquid chromatography, laboratory biomarker analysis, mass spectrometry - Prostate Cancer | Completed | Barbara Ann Karmanos Cancer Institute | 10 | 2009-11-01 | 2016-02-15 | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme temozolomide, veliparib, DNA methylation analysis - Brain and Central Nervous System Tumors | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 24 | 2009-07-13 | 2018-06-27 |
| Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery curcumin, high performance liquid chromatography, laboratory biomarker analysis - Colorectal Cancer | Phase 1 | Unknown | University of Leicester | 30 | 2009-07-01 | 2014-06-24 |
| Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer dextromethorphan hydrobromide, tamoxifen citrate, high performance liquid chromatography - Breast Cancer | Terminated | Mayo Clinic | 92 | 2009-05-01 | 2018-01-23 | |
| Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105 high performance liquid chromatography, laboratory biomarker analysis, mass spectrometry - Breast Cancer | Completed | University of Nebraska | 100 | 2009-02-02 | 2023-09-01 | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy high performance liquid chromatography, pharmacological study, radionuclide imaging - Lung Cancer | Phase 1 | Completed | City of Hope Medical Center | 10 | 2008-10-13 | 2026-10-15 |
| Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment hydroxychloroquine, temsirolimus, electron microscopy - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 40 | 2008-10-01 | 2019-04-16 |
| White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors white button mushroom extract, flow cytometry, high performance liquid chromatography - Breast Cancer, Cancer Survivor | Phase 1 | Completed | City of Hope Medical Center | 16 | 2008-06-01 | 2015-06-08 |
| Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia DNA analysis, DNA methylation analysis, gene expression analysis - Leukemia | Unknown | Alliance for Clinical Trials in Oncology | 529 | 2008-06-01 | 2023-08-31 | |
| Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors hydroxychloroquine, temozolomide, TdT-mediated dUTP nick end labeling assay - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 38 | 2008-06-01 | 2016-02-18 |
| Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma rituximab, clofarabine, DNA methylation analysis - Lymphoma | Phase 1 / Phase 2 | Terminated | OHSU Knight Cancer Institute | 2 | 2008-05-01 | 2019-11-27 |
| A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma buthionine sulfoximine, melphalan, microarray analysis - Melanoma (Skin) | Phase 1 | Withdrawn | Duke University | 2008-04-01 | 2015-03-13 | |
| Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection S-adenosyl-L-methionine disulfate p-toluene-sulfonate, placebo, laboratory biomarker analysis - Adult Primary Liver Cancer, Hepatitis C Infection | Phase 2 | Completed | Chao Family Comprehensive Cancer Center | 110 | 2007-10-01 | 2018-08-10 |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer high performance liquid chromatography, pharmacological study, [18F]-labeled substance P antagonist receptor quantifier - Pancreatic Cancer | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 33 | 2007-09-01 | 2012-03-16 |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer polymorphism analysis, high performance liquid chromatography, laboratory biomarker analysis - Breast Cancer | Completed | Alliance for Clinical Trials in Oncology | 140 | 2007-09-01 | 2016-07-13 | |
| DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements cholecalciferol, polymerase chain reaction, polymorphism analysis - Colorectal Cancer | Not applicable | Completed | Roswell Park Cancer Institute | 50 | 2007-08-01 | 2017-04-04 |
Showing 20 of 37. Sign in to see all of them.
Breast Neoplasms (12) · Melanoma (4) · Carcinoma, Intraductal, Noninfiltrating (3) · Prostatic Neoplasms (3) · Breast Carcinoma In Situ (2) · Carcinoma, Non-Small-Cell Lung (2) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Congenital Abnormalities (2) · Hepatitis C (2) · Lung Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Rectal Neoplasms (2) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1)
City of Hope Medical Center (5) · Mayo Clinic (4) · National Cancer Institute (NCI) (3) · University of Nebraska (3) · Abramson Cancer Center at Penn Medicine (2) · Alliance for Clinical Trials in Oncology (2) · OHSU Knight Cancer Institute (2) · Barbara Ann Karmanos Cancer Institute (1) · Brigham and Women's Hospital (1) · Cairo University (1) · Case Comprehensive Cancer Center (1) · Chao Family Comprehensive Cancer Center (1) · Duke University (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Iceland Genomics Corporation (1)
United States (29) · United Kingdom (3) · Belgium (1) · Canada (1) · Egypt (1) · Iceland (1)
Ercole Cavalieri, DSc (2) · James N. Ingle, MD (2) · Jeffrey Y. Wong, MD (2) · Ravi Amaravadi, MD (2) · Stephen I. Shibata, MD (2) · Alisa Goldstein, PhD (1) · Angela Cox, PhD (1) · Anthony Leathem, MD (1) · Barry J. Maurer, MD, PhD (1) · Bruce S. Kristal, PhD (1) · Clara Bloomfield, MD (1) · Craig Okada, MD, PhD (1) · Donald W. Northfelt, M.D. (1) · Donald W. Northfelt, MD, FACP (1) · Douglas S. Tyler, MD (1)
PMID 20354183, PMID 20368434, PMID 20442368, PMID 20471824, PMID 22044694, PMID 23518928, PMID 25148458, PMID 26130251, PMID 26242208, PMID 31375516, PMID 34162404, PMID 34847232, PMID 36823396, PMID 37196637, PMID 38017103, PMID 38702786, PMID 39283025
P30CA033572 (5), P30CA036727 (2), N01CM62207 (1), N01CN35158 (1), N01CN35160 (1), P01CA043904 (1), P01CA081403 (1), P01HL048546 (1), P30CA015083 (1), P30CA022453 (1), P30CA069533 (1), R01CA102536 (1), U01CA062475 (1), U01CA070095 (1)